These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2181873)
1. Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes. Watts NB; DiGirolamo M Am J Med Sci; 1990 Apr; 299(4):250-6. PubMed ID: 2181873 [TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Féry F; Balasse EO Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493 [TBL] [Abstract][Full Text] [Related]
3. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM. Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004 [TBL] [Abstract][Full Text] [Related]
4. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. McMahon M; Marsh HM; Rizza RA Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963 [TBL] [Abstract][Full Text] [Related]
5. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo. Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. DeFronzo RA; Barzilai N; Simonson DC J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512 [TBL] [Abstract][Full Text] [Related]
7. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast. Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502 [TBL] [Abstract][Full Text] [Related]
8. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus. Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695 [TBL] [Abstract][Full Text] [Related]
9. Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control. Boden G; Ray TK; Smith RH; Owen OE Diabetes; 1983 Nov; 32(11):982-7. PubMed ID: 6315513 [TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Frias JP; Yu JG; Kruszynska YT; Olefsky JM Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970 [TBL] [Abstract][Full Text] [Related]
11. Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM). Osei K; Cottrell DA; Bossetti B Int J Obes; 1991 Jul; 15(7):441-51. PubMed ID: 1894421 [TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716 [TBL] [Abstract][Full Text] [Related]
13. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885 [TBL] [Abstract][Full Text] [Related]
14. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922 [TBL] [Abstract][Full Text] [Related]
15. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Christiansen E; Schnider S; Palmvig B; Tauber-Lassen E; Pedersen O Diabetes Care; 1997 May; 20(5):881-7. PubMed ID: 9135961 [TBL] [Abstract][Full Text] [Related]
16. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Konrad T; Vicini P; Kusterer K; Höflich A; Assadkhani A; Böhles HJ; Sewell A; Tritschler HJ; Cobelli C; Usadel KH Diabetes Care; 1999 Feb; 22(2):280-7. PubMed ID: 10333946 [TBL] [Abstract][Full Text] [Related]
17. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Robertson MD; Henderson RA; Vist GE; Rumsey RD Am J Clin Nutr; 2002 Mar; 75(3):505-10. PubMed ID: 11864856 [TBL] [Abstract][Full Text] [Related]
18. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin. Ubukata E Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus. Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037 [TBL] [Abstract][Full Text] [Related]